RxDoctor Payments Data

Caroline Martin, DO

Family Medicine · Lees Summit, MONPI 1346627049

Payments from drug & device makers

$496in general payments, 2019–2025

Across 32 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$103
  • AstraZeneca$62
  • AbbVie$59
  • Novo Nordisk$44
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$42
  • Takeda Pharmaceuticals U.S.A., Inc.$39
  • plus $148 from 9 others

What the payments were for

  • Food & beverage$496100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$496 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$95,434
Medicare patients
185
Services billed
833

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban431$156,482
AustedoDeutetrabenazine25$91,046
OzempicSemaglutide51$53,825
MyrbetriqMirabegron144$39,728
XareltoRivaroxaban97$34,494
JardianceEmpagliflozin67$23,316
LinzessLinaclotide27$15,989
MovantikNaloxegol Oxalate77$15,191
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,151
Memantine Hcl274$12,825
RestasisCyclosporine26$11,224
NamzaricMemantine Hcl/Donepezil Hcl25$8,945
SymbicortBudesonide/Formoterol Fumarate30$7,149
JanuviaSitagliptin Phosphate24$7,038
Potassium Chloride390$6,925

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$44$53,82551 claims
AbbVieLinzess, Restasis, Namzaric, Lumigan$59$39,57591 claims
Boehringer IngelheimJardiance$26$23,31667 claims
MerckJanuvia, Janumet$12$10,26636 claims
AstraZenecaSymbicort$62$7,14930 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Lees Summit

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →